ClinicNew method to determine the risk of skin cancer relapse
BMBF-funding for MelEVIR How likely do patients develop cancer again after a tumor has been surgically removed? This is the central question of the new research project „MelEVIR – Melanoma, Extracellular Vesicles, and Immune Response“ that will be funded by the German Ministry of Education and Research (BMBF) with overall 1.3 million Euro. The project started […]BMBF-funding for MelEVIR How likely do patients develop cancer again after a tumor has been surgically removed? This is the central question of the new research project „MelEVIR – Melanoma, Extracellular Vesicles, and Immune Response“ that will be funded by the German Ministry of Education and Research (BMBF) with overall 1.3 million Euro. The project started […]
